| answer text |
<p>The research is an ethically approved study being carried out by the Tavistock
and Portman NHS Foundation Trust since 2011, which is the largest provider of services
for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will
evaluate early pubertal suppression in a carefully selected group of adolescents with
a clinical diagnosis of gender dysphoria. There are 44 young people taking part in
the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish
the data <ins class="ministerial">on the blocker and cross-sex hormones, for those
who were appropriate for this, as</ins><del class="ministerial">once</del> all of
the young people in the study have reached <ins class="ministerial">this</ins><del
class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when
a clinical decision is made about moving from pubertal suppressants to cross-sex hormones,
which the Trust expects to occur in the next 12 months.</del></p>
|
|
